NU Skin Enterprises Inc

The asset is firmly in a Stage 4 decline with dominant lower highs and lower lows, down-trending moving averages, and persistent distribution. Medium-term bias is bearish, supported by structural downtrend and bearish pattern implications. Short-term price has attempted a bounce but was rejected at falling EMAs, indicating execution readiness for selling. The long-term secular trend remains negative. Risks include possible oversold mean-reversion bounces and a reclaim of EMAs that could signal a reversal.

• ↑Latin America Q2 revenue up 100% YoY shows emerging market strength
• ↑Prism IO platform launch expected to boost personalized wellness sales
• ↓North America growth stalled, signaling challenges in core market